Evidence map›Paper›PMID 37698668›Full record

ArticleAnnals of surgical oncology2023

Comparison of Clinical Efficacy Between Da Vinci Robot-Assisted Ivor Lewis Esophagectomy and McKeown Esophagectomy for Middle and Lower Thoracic Esophageal Cancer: A Multicenter Propensity Score-Matched Study.

Ziqiang Hong, Baiqiang Cui, Kai Wang, Xiangdou Bai, Ning Yang, Yu Zhang, Xusheng Wu, Tao Cheng, Dacheng Jin, Jing Zhao and 1 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Ziqiang HongDepartment of Thoracic Surgery, Gansu Provincial Hospital, Lanzhou, China.
Baiqiang CuiDepartment of Thoracic Surgery, Second Hospital of Lanzhou University, Lanzhou, China.
Kai WangDepartment of Thoracic Surgery, Gansu Provincial Hospital, Lanzhou, China.
Xiangdou BaiDepartment of Thoracic Surgery, Gansu Provincial Hospital, Lanzhou, China.
Ning YangDepartment of Thoracic Surgery, Second Hospital of Lanzhou University, Lanzhou, China.
Yu ZhangDepartment of Thoracic Surgery, First Hospital of Lanzhou University, Lanzhou, China.
Xusheng WuDepartment of Thoracic Surgery, Gansu Provincial Hospital, Lanzhou, China.
Tao ChengDepartment of Thoracic Surgery, Gansu Provincial Hospital, Lanzhou, China.
Dacheng JinDepartment of Thoracic Surgery, Gansu Provincial Hospital, Lanzhou, China.
Jing ZhaoLanzhou First People's Hospital, Lanzhou, China. hi18786794674@163.com.
Yunjiu GouDepartment of Thoracic Surgery, Gansu Provincial Hospital, Lanzhou, China. hi15178546851@163.com.
Gansu Provincial Hospital · CNFirst Hospital of Lanzhou University · CNLanzhou University Second Hospital · CN

Funding

Gansu Province Key R&D Project (22YF7FA095)
6 · The paper itself

Abstract

backgroundWe compared the perioperative efficacy and safety of da Vinci robot-assisted Ivor Lewis esophagectomy and McKeown esophagectomy for middle and lower thoracic esophageal cancer.

methodsA retrospective case-control study method was used. A total of 181 patients with esophageal cancer admitted to three medical centers in China from February 2018 to October 2022 were collected and divided into two groups according to surgical method: da Vinci robot-assisted thoracic surgery (RATS) Ivor Lewis esophagectomy (Ivor Lewis group) and RATS McKeown esophagectomy (McKeown group), respectively. Propensity score matching (PSM) analysis was used to reduce selection bias caused by confounding factors. The perioperative indicators of the two groups were compared and analyzed.

resultsThere was a statistically significant difference in age and tumor location between the Ivor Lewis group and the McKeown group. After PSM, the above factors were no longer statistically significant. There were 80 patients in each group after PSM. In terms of operative time (P = 0.005), anastomotic leakage (P = 0.029), and pulmonary infection (P = 0.035), the Ivor Lewis group has significant advantages; in terms of the number of lymph nodes dissected around the recurrent laryngeal nerve (P = 0.010), the McKeown group has significant advantages.

conclusionBoth RATS Ivor Lewis esophagectomy and McKeown esophagectomy are safe and effective for treatment of middle and lower thoracic esophageal cancer. Ivor Lewis has advantages in operative time, anastomotic leakage, and pulmonary infection, while McKeown has advantage in lymph node dissection around the recurrent laryngeal nerve.

Indexed as

Esophageal NeoplasmsRoboticsAnastomotic LeakAnimalsCase-Control StudiesEsophagectomyHumansPostoperative ComplicationsPropensity ScoreRatsRats, Inbred LewRetrospective StudiesTreatment OutcomeEsophageal cancerIvor LewisMcKeownMulticenter retrospective studyPropensity score matching analysisRobot-assisted thoracic surgery

Identifiers

PMID37698668
OpenAlexW4386624659

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.